Skip to main content
SpringerLink
Log in
Book cover

Devices for Cardiac Resynchronization pp 105–122Cite as

Cardiac Resynchronization for Heart Failure: Do We Need More Trials?

  • Chapter

  • 668 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hochleitner M, Hortnagl H, Choi-Keung N, et al. Usefulness of physiologic dual-chambered pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990;66:198–202.

    Article  PubMed  CAS  Google Scholar 

  2. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to update the 1998 pacemaker guidelines). Circulation 2002;106:2145–61.

    Article  PubMed  Google Scholar 

  3. Hunt SA, Abraham WT, Chin SA, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005;112:154–235.

    Article  Google Scholar 

  4. Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352(15):1539–49.

    Article  PubMed  CAS  Google Scholar 

  5. Stellbrink C, Breithardt OA, Franke A, et al. PATH-CHF (PAcing THerapies in Congestive Heart Failure) Investigators; CPI Guidant Congestive Heart Failure Research Group. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol 2001;38(7):1957–65.

    Article  PubMed  CAS  Google Scholar 

  6. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–53.

    Article  PubMed  Google Scholar 

  7. Young JB, Abraham WT, Smith AL, et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD trial. JAMA 2003;289:2685–94.

    Article  PubMed  Google Scholar 

  8. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873–80.

    Article  PubMed  CAS  Google Scholar 

  9. U.S. FDA. Summary of Safety and Effectiveness: Guidant CONTAK CD CRT-D System. U.S. Food and Drug Administration. Available at: http://www.fda. gov/cdrh/pdf/p010012.html.

    Google Scholar 

  10. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140–50.

    Article  PubMed  CAS  Google Scholar 

  11. Foster A, Gold M, McGlaughlin J. Acute hemodynamic effects of atrio-biventricular pacing in humans. Ann Thorac Surg 1995;59:294–300.

    Article  PubMed  CAS  Google Scholar 

  12. Cazeau S, Ritter P, Lazarus A, et al. Multisite pacing for end-stage heart failure: early experience. PACE 1996;19(Pt II):1742–57.

    Google Scholar 

  13. Leclercq C, Cazeau S, Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998;32:1825–31.

    Article  PubMed  CAS  Google Scholar 

  14. Hamdan M, Zagrodsky J, Joglar J, et al. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 2000;102:1027–32.

    PubMed  CAS  Google Scholar 

  15. Kass D, Chen-Hyan C, Curry C, et al. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999;99:1567–73.

    PubMed  CAS  Google Scholar 

  16. Innes D, Keitch J, Fletcher P, et al. VDD pacing at short atrioventricular intervals does not improve cardiac output in patients with dilated heart failure [abstract]. PACE 1994;17:959.

    PubMed  CAS  Google Scholar 

  17. Linde C, Gadler F, Edner M, et al. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure [abstract]. Am J Cardiol 1995;75:919.

    Article  PubMed  CAS  Google Scholar 

  18. Brecker S, Gibson D. What is the role of pacing in dilated cardiomyopathy? Eur Heart J 1996;17:819.

    PubMed  CAS  Google Scholar 

  19. Leclercq C, Cazeau S, Ritter P, et al. A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J 2000;140(6):862–70.

    Article  PubMed  CAS  Google Scholar 

  20. Gras D, Leclercq C, Tang AS, et al. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 2002;4(3): 311–20.

    Article  PubMed  Google Scholar 

  21. Kuhlkamp V, InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002;39(5):790–7.

    Article  PubMed  Google Scholar 

  22. Flather MD, Yusuf S, Kober L, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000;355:1575–81.

    Article  PubMed  CAS  Google Scholar 

  23. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001;134:550–60.

    PubMed  CAS  Google Scholar 

  24. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709–17.

    Article  PubMed  CAS  Google Scholar 

  25. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309–21.

    Article  PubMed  CAS  Google Scholar 

  26. Rector TS, Cohn JN. Assessment of patient outcome with the MinnesotaLiving with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 1992;124:1017–25.

    Article  PubMed  CAS  Google Scholar 

  27. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 1993;71:1106–7.

    Article  PubMed  CAS  Google Scholar 

  28. Rector TS, Johnson G, Dunkman WB, et al. Evaluation by patients with heart failure of the effects of enalapril compared with hydralazine plus isosorbide dinitrate on quality of life. V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87:VI71–7.

    PubMed  CAS  Google Scholar 

  29. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667–75.

    Article  PubMed  CAS  Google Scholar 

  30. Hjalmarson A, Goldstein S, Fagerberg B, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 2000;283:1295–302.

    Article  PubMed  CAS  Google Scholar 

  31. Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA 2003;289(6):730–40.

    Article  PubMed  Google Scholar 

  32. McAlister FA, Ezekowitz JA, Wiebe N, et al. Systematic review: Cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 2004;141:381–90.

    PubMed  Google Scholar 

  33. Davis DR, Krahn AD, Tang ASL, et al. Long-term outcome of cardiac resynchronization therapy in patients with severe congestive heart failure. Can J Cardiol 2005;21:413–7.

    PubMed  Google Scholar 

  34. Bax JJ, Ansalone G, Breithardt OA, et al. Echocardiographic evaluation of cardiac resynchronization therapy: Ready for routine clinical use? A critical appraisal. J Am Coll Cardiol 2004;44:1–9.

    Article  PubMed  Google Scholar 

  35. Yu CM, Fung WH, Lin H, et al. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2003;91:684–88.

    Article  PubMed  Google Scholar 

  36. Kim WY, Sogaard P, Mortensen PT, et al. Three dimensional echocardiography documents haemodynamic improvement by biventricular pacing in patients with severe heart failure. Heart 2001;85:514–20.

    Article  PubMed  CAS  Google Scholar 

  37. Pitzalis MV, Iacoviello M, Romito R, et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. J Am Coll Cardiol 2002;40:1615–22.

    Article  PubMed  Google Scholar 

  38. Reuter S, Garrigue S, Barold SS, et al. Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure. Am J Cardiol 2002;89:346–50.

    Article  PubMed  Google Scholar 

  39. Sogaard P, Egeblad H, Kim WY, et al. Tissue Doppler imaging predicts improved systolic performance and reversed left ventricular remodeling during long-term cardiac resynchronization therapy. J Am Coll Cardiol 2002;40:723–30.

    Article  PubMed  Google Scholar 

  40. Rossillo A, Verma A, Saad EB, et al. Impact of coronary sinus lead position on biventricular pacing: Mortality and echocardiographic evaluation during long-term follow-up. J Cardiovasc Electrophysiol 2004;15:1120–25.

    Article  PubMed  Google Scholar 

  41. Auricchio A, Fantoni C. Cardiac resynchronization therapy in heart failure. Ital Heart J 2005;6(3):256–60.

    PubMed  Google Scholar 

  42. Bardy GH, Lee KL, Mark DB, et al, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225–37.

    Article  PubMed  CAS  Google Scholar 

  43. Ellenbogen KA, Hellkamp AS, Wilkoff BL, et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol 2003;92:740–1.

    Article  PubMed  Google Scholar 

  44. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med 2003;138:445–52.

    PubMed  Google Scholar 

  45. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42: 1454–59.

    Article  PubMed  Google Scholar 

  46. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39:2026–33.

    Article  PubMed  Google Scholar 

  47. Garrigue S, Bordachar P, Reuter S, et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study. Heart 2002;87:529–34.

    Article  PubMed  CAS  Google Scholar 

  48. Leclercq C, Cazeau S, Lellouche D, et al. Upgrading from right ventricular pacing to biventricular pacing in previously paced patients with advanced heart failure: A randomized controlled study [the RD-CHF Trial] [abstract]. Presented at the European Society of Cardiology Congress, Vienna, Austria, 30 August–3 September 2003.

    Google Scholar 

  49. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780–7.

    Article  PubMed  CAS  Google Scholar 

  50. Turner MS, Bleasdale RA, Vinereanu D, et al. Electrical and mechanical components of dyssynchrony in heart failure patients with normal QRS duration and left bundle-branch block: Impact of left and biventricular pacing. Circulation 2004;109:2544–9.

    Article  PubMed  Google Scholar 

  51. Leon A, Greenberg J, Kanaru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation. J Am Coll Cardiol 2002;39(8):1258–63.

    Article  PubMed  Google Scholar 

  52. Doshi R, Daoud E, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (The PAVE Study). J Cardiovasc Electrophysiol 2005;16(11):1160–5.

    Article  PubMed  Google Scholar 

  53. Hoppe U, Cesares J, Eiskjaer H, et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006;114(1):18–25.

    Article  PubMed  Google Scholar 

  54. Padeletti L, Musilli N, Porciani M, et al. Atrial fibrillation and cardiac resynchronization therapy: the MASCOT Study. Europace 2004;5(Suppl 1):S49–54.

    Article  PubMed  Google Scholar 

  55. Aranda J, Conti J, Johnson J, et al. Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle branch block: analysis of the Multicenter InSync Randomized Clinical Evaluation. Clin Cardiol 2004;27(12):678–82.

    Article  PubMed  Google Scholar 

  56. Egoavil C, Ho R, Greenspoon A, et al. Cardiac resynchronization therapy in patients with right bundle branch block: Analysis of pooled data from the MIRACLE and CONTAK CD Trials, Comment. Heart Rhythm 2005;2(6):616–8.

    Article  Google Scholar 

  57. Achilli A, Sassara M, Ficili S, et al. Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and narrow QRS. J Am Coll Cardiol 2003;42:2117–24.

    Article  PubMed  Google Scholar 

  58. Yu C, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003;89:54–60.

    Article  PubMed  Google Scholar 

  59. Yu C, Fung W, Lin H, et al. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 2002;91:684–8.

    Article  Google Scholar 

  60. Yu C, Abraham W, Bax J, Chung E, et al. PROSPECT Investigators. Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design. Am Heart J 2005;149(4):600–5.

    Article  PubMed  Google Scholar 

  61. Kedia N, Ng K, Apperson-Hansen C, et al. Usefulness of atrioventricular delay optimization using doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. Am J Cardiol 2006;98:780–5.

    Article  PubMed  Google Scholar 

  62. Butter C, Auriccio A, Stellbrink C, et al. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104:3026–9.

    Article  PubMed  CAS  Google Scholar 

  63. Murphy R, Sigurdsson G, Mulamalla S, et al. Tissue synchronization imaging and optimal left ventricular pacing site in cardiac resynchronization therapy. Am J Cardiol 2006;97(11)1615–21.

    Article  PubMed  Google Scholar 

  64. Linde C, Gold M, Abraham W, et al., REVERSE Study Group. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure. Am Heart J 2006;151(2):288–94.

    Article  PubMed  Google Scholar 

  65. Moss A, Zareba W, Hall W, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877–83.

    Article  PubMed  Google Scholar 

  66. DAVID Trial Investigators. Dual chamber or ventricular backup pacing in patients with an implantable defibrillator. JAMA 2002;288(24):3115–23.

    Google Scholar 

Download references

Authors
  1. Sunil T. Mathew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christina M. Murray
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dwight W. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Professor of Medicine, University of South Florida College of Medicine and Division of Cardiology Tampa General Hospital, Tampa, Florida, USA

    S. Serge Barold MD, FRACP, FACP FACC, FESC, FHRS

  2. Chairman, Cardiostim InParys, St Cloud Clinique Bizet, Paris Clinique Chirurgicale Val d’Or, St Cloud, Paris, France

    Philippe Ritter MD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Mathew, S.T., Murray, C.M., Reynolds, D.W. (2008). Cardiac Resynchronization for Heart Failure: Do We Need More Trials?. In: Barold, S.S., Ritter, P. (eds) Devices for Cardiac Resynchronization. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-71167-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-71167-6_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-71166-9

  • Online ISBN: 978-0-387-71167-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation